Loading company…
Miroculus develops Miro personal lab automation tools for biotech research, including the Miro Canvas product.
Miroculus researches and develops biotech tools for personal lab automation, built on its Miro technology platform for workflows from NGS sample preparation to small molecule chemistry and synthetic biology. Based in California, US, and founded in 2014, the company was co-founded by Alejandro Tocigl (CEO), Fay Christodoulou (Chief Scientific Officer) and Jorge Soto. It closed Series B financing in February 2021, bringing total capital raised in the series to USD 45 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in